Connect with us

Business

Third member of US FDA advisory panel resigns over Alzheimer’s drug approval – Fox Business

Published

on

Article feature image
ADVERTISEMENT

A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency’s decision to approve Biogen Inc’s Alzheimer’s disease treatment despite the committee’s recommendation against doing so.
Aaron…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
American Express CEO says U.S. travel, dining spending is nearing full recovery – CNBC
Article feature image
New Tesla Model S Long Range Gets Official EPA Range Rating – InsideEVs
Article feature image
Summer vacation? Amtrak Rail Pass offers 10 trips for $299 with passes available through June 22 – USA TODAY